Liver Surface Nodularity Publications

2.

Smith AD, Porter KK, Elkassem AA, Sanyal R, Lockhart ME. Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis. AJR Am J Roentgenol. 2019 Apr 11;:1-13.

3.

Smith A, Varney E, Zand K, Lewis T, Sirous R, York J, Florez E, Abou Elkassem A, Howard-Claudio CM, Roda M, Parker E, Scortegagna E, Joyner D, Sandlin D, Newsome A, Brewster P, Lirette ST, Griswold M. Precision analysis of a quantitative CT liver surface nodularity score. Abdom Radiol (NY). 2018 Dec;43(12):3307-3316

4.

Lubner MG, Jones D, Said A, Kloke J, Lee S, Pickhardt PJ. Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus. Abdom Radiol (NY). 2018 Nov;43(11):2980-2986.

5.

Sartoris R, Rautou PE, Elkrief L, Pollorsi G, Durand F, Valla D, Spahr L, Terraz S, Soubrane O, Cauchy F, Vilgrain V, Ronot M. Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension. Radiology. 2018 Dec;289(3):698-707.

6.

Lubner MG, Pickhardt PJ. Multidetector Computed Tomography for Retrospective, Noninvasive Staging of Liver Fibrosis. Gastroenterol Clin North Am. 2018 Sep;47(3):569-584.

7.

Besa C, Wagner M, Lo G, Gordic S, Chatterji M, Kennedy P, Stueck A, Thung S, Babb J, Smith A, Taouli B. Detection of liver fibrosis using qualitative and quantitative MR elastography compared to liver surface nodularity measurement, gadoxetic acid uptake, and serum markers. J Magn Reson Imaging. 2018 Jun;47(6):1552-1561.

8.

Lubner MG, Pickhardt PJ. Multidetector Computed Tomography for Retrospective, Noninvasive Staging of Liver Fibrosis. Gastroenterol Clin North Am. 2018 Sep;47(3):569-584.

9.

Lo GC, Besa C, King MJ, Kang M, Stueck A, Thung S, Wagner M, Smith AD, Taouli B. Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRI. Eur J Radiol Open. 2017;4:95-100.

10.

Pickhardt PJ, Malecki K, Kloke J, Lubner MG. Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis. AJR Am J Roentgenol. 2016 Dec;207(6):1194-1199.

11.

Smith AD, Branch CR, Zand K, Subramony C, Zhang H, Thaggard K, Hosch R, Bryan J, Vasanji A, Griswold M, Zhang X. Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis. Radiology. 2016 Sep;280(3):771-81.

12.

Sartoris R, Lazareth M, Nivolli A, Dioguardi Burgio M, Vilgrain V, Ronot M. CT-based liver surface nodularity for the detection of clinically significant portal hypertension: defining measurement quality criteria [published online ahead of print, 2020 Apr 8]. Abdom Radiol (NY). 2020;10.1007/s00261-020-02519-1. 

Tel: 205.573.3332

1500 First Ave N, Birmingham, AL 35203